Paper-Conference

The Effects of Pooling Treatment Effects Targeting Treatment Policy and Hypothetical Estimands With Rank-Preserving Structural Failure Time Model in Oncology Aggregate-Level Meta-Analyses

Can Estimands Support Aligned Evidence Generation for EU HTA? Reflections on Their Role in Joint Clinical Assessments, PICO Alignment, and Beyond

The Importance of Specifying the Estimand in Meta-Analyses in the Presence of Treatment Switching

Treatment Switching in Evidence Synthesis in Oncology: A Comprehensive Review of Current Meta-Analytical Practices

The ICH E9 (R1) Estimand Framework in the Context of Real-World Data and Observational Studies

Estimands and Strategies for Handling Treatment Switching As an Intercurrent Event in Evidence Synthesis of Randomized Clinical Trials in Oncology

Estimands in Health Technology Assessments - Methodological Considerations and Recommendations

Assessing the Impact of Modeling Non-Disease-Related Mortality on Long-Term Survivorship Rates in Previously Untreated Advanced Melanoma - A Case Study from CheckMate 067

Estimating long-term survivorship in patients with advanced melanoma treated with immune-checkpoint inhibitors - Analyses from the phase III CheckMate 067 trial

Matching-Adjusted Indirect Comparison of Cabozantinib Versus Regorafenib in Advanced Hepatocellular Carcinoma